Patents by Inventor Kenjiro Sato
Kenjiro Sato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11963576Abstract: A sole structure for a shoe includes an upper wall portion disposed on the upper side, a lower wall portion disposed below and away from the upper wall portion, and a sidewall portion that is disposed between the upper wall portion and the lower wall portion and that is elastically deformable in the vertical direction. The upper and lower wall portions and the sidewall portion are formed of resin-made wall-shaped members. A three-dimensional elastic fiber structure formed of resin fibers is provided in the interior region between the upper wall portion and the lower wall portion. The interior region includes a hollow portion that is in contact with the three-dimensional elastic fiber structure via a partition wall formed of a resin-made wall-shaped member.Type: GrantFiled: March 23, 2021Date of Patent: April 23, 2024Assignee: MIZUNO CORPORATIONInventors: Kenjiro Kita, Takao Oda, Natsuki Sato, Yo Kajiwara, Shingo Sudo
-
Publication number: 20240043470Abstract: The compounds of the present invention are represented by the following compounds having Formula I and Formula (I?): where the substituents R1, R2, R2?, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: September 25, 2023Publication date: February 8, 2024Inventors: Gang LIN, Carl NATHAN, Laura KIRKMAN, Wenhu ZHAN, Trevor MORGAN, Kenjiro SATO, Ryoma HARA, Masanori KAWASAKI, Toshihiro IMAEDA, Akinori TOITA, Rei OKAMOTO, Takafumi YUKAWA, Kazuyoshi ASO, Tzu-Tshin WONG, John D. GINN, Michael A. FOLEY
-
Patent number: 11834515Abstract: The compounds of the present invention are represented by the following compounds having Formula I and Formula (I?): where the substituents R1, R2, R2?, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: GrantFiled: October 11, 2018Date of Patent: December 5, 2023Assignees: CORNELL UNIVERSITY, TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTEInventors: Gang Lin, Carl Nathan, Laura Kirkman, Wenhu Zhan, Trevor Morgan, Kenjiro Sato, Ryoma Hara, Masanori Kawasaki, Toshihiro Imaeda, Akinori Toita, Rei Okamoto, Takafumi Yukawa, Kazuyoshi Aso, Tzu-Tshin Wong, John D. Ginn, Michael A. Foley
-
Patent number: 11732005Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3, R4, R, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: GrantFiled: November 8, 2021Date of Patent: August 22, 2023Assignees: CORNELL UNIVERSITY, TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTEInventors: Gang Lin, Carl Nathan, Wenhu Zhan, Trevor Morgan, Ryoma Hara, Toshihiro Imaeda, Rei Okamoto, Kenjiro Sato, Kazuyoshi Aso, Tzu-Tshin Wong, Michael A. Foley
-
Patent number: 11495331Abstract: An objective of the present invention is to provide a document creation assistance server and document creation assistance method which are capable of efficiently acquiring information necessary to write a specification or other such documents, and of generating a document from the acquired information.Type: GrantFiled: September 10, 2018Date of Patent: November 8, 2022Assignees: TAKEDA PHARMACEUTICAL COMPANY LIMITED, PATCORE, INC.Inventors: Hiroshi Nara, Junya Shirai, Tatsuki Koike, Kenjiro Sato, Takaharu Hirayama, Hiromi Fukuda, Tsutomu Morita, Hiromasa Ishihara, Kazue Suzuki, Hiroki Sakamoto, Fumiaki Kikuchi, Kenta Tamaki, Toru Tanoue, Yuichi Horita, Takeshi Ueda
-
Publication number: 20220324907Abstract: The compounds of the present invention are represented by the following compounds having Formula I and Formula (I?): where the substituents R1, R2, R2?, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: October 11, 2018Publication date: October 13, 2022Inventors: Gang LIN, Carl NATHAN, Laura KIRKMAN, Wenhu ZHAN, Trevor MORGAN, Kenjiro SATO, Ryoma HARA, Masanori KAWASAKI, Toshihiro IMAEDA, Akinori TOITA, Rei OKAMOTO, Takafumi YUKAWA, Kazuyoshi ASO, Tzu-Tshin WONG, John D. GINN, Michael A. FOLEY
-
Publication number: 20220056073Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3, R4, R, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: November 8, 2021Publication date: February 24, 2022Inventors: Gang LIN, Carl NATHAN, Wenhu ZHAN, Trevor MORGAN, Ryoma HARA, Toshihiro IMAEDA, Rei OKAMOTO, Kenjiro SATO, Kazuyoshi ASO, Tzu-Tshin WONG, Michael A. FOLEY
-
Patent number: 11203613Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3 R4, R?, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: GrantFiled: October 11, 2018Date of Patent: December 21, 2021Inventors: Gang Lin, Carl Nathan, Wenhu Zhan, Trevor Morgan, Ryoma Hara, Toshihiro Imaeda, Rei Okamoto, Kenjiro Sato, Kazuyoshi Aso, Tzu-Tshin Wong, Michael A. Foley
-
Patent number: 10919891Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: GrantFiled: April 26, 2018Date of Patent: February 16, 2021Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Shuji Kitamura, Zenichi Ikeda, Sachie Morimoto, Minoru Ikoma, Koji Watanabe, Hideki Hirose, Takafumi Yukawa, Kenjiro Sato
-
Patent number: 10875862Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: GrantFiled: April 26, 2018Date of Patent: December 29, 2020Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Shuji Kitamura, Zenichi Ikeda, Sachie Morimoto, Minoru Ikoma, Koji Watanabe, Hideki Hirose, Takafumi Yukawa, Kenjiro Sato
-
Publication number: 20200388354Abstract: An objective of the present invention is to provide a document creation assistance server and document creation assistance method which are capable of efficiently acquiring information necessary to write a specification or other such documents, and of generating a document from the acquired information.Type: ApplicationFiled: September 10, 2018Publication date: December 10, 2020Inventors: Hiroshi NARA, Junya SHIRAI, Tatsuki KOIKE, Kenjiro SATO, Takaharu HIRAYAMA, Hiromi FUKUDA, Tsutomu MORITA, Hiromasa ISHIHARA, Kazue SUZUKI, Hiroki SAKAMOTO, Fumiaki KIKUCHI, Kenta TAMAKI, Toru TANOUE, Yuichi HORITA, Takeshi UEDA
-
Publication number: 20200317729Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3 R4, R?, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: October 11, 2018Publication date: October 8, 2020Inventors: Gang LIN, Carl NATHAN, Wenhu ZHAN, Trevor MORGAN, Ryoma HARA, Toshihiro IMAEDA, Rei OKAMOTO, Kenjiro SATO, Kazuyoshi ASO, Tzu-Tshin WONG, Michael A. FOLEY
-
Publication number: 20200131174Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: ApplicationFiled: April 26, 2018Publication date: April 30, 2020Inventors: Shuji KITAMURA, Zenichi IKEDA, Sachie MORIMOTO, Minoru IKOMA, Koji WATANABE, Hideki HIROSE, Takafumi YUKAWA, Kenjiro SATO
-
Patent number: 9475822Abstract: The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X? is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl} 5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded,Type: GrantFiled: July 29, 2015Date of Patent: October 25, 2016Assignee: Takeda Pharmaceutical Company LimitedInventors: Jun Terauchi, Hiroshi Nara, Hideyuki Oki, Kenjiro Sato
-
Patent number: 9212149Abstract: The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen-containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X? is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-5,6-dimethyl-4-oxo-1,4-dihadrothieno[2,3-d]pyrimidine-2-carboxamide is excludeType: GrantFiled: April 28, 2005Date of Patent: December 15, 2015Assignee: Takeda Pharmaceutical Company LimitedInventors: Jun Terauchi, Hiroshi Nara, Hideyuki Oki, Kenjiro Sato
-
Publication number: 20150329556Abstract: The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X? is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded,Type: ApplicationFiled: July 29, 2015Publication date: November 19, 2015Inventors: Jun Terauchi, Hiroshi Nara, Hideyuki Oki, Kenjiro Sato
-
Patent number: 8020229Abstract: A pillow for enabling a patient with whiplash syndrome to sleep peacefully including a deformable pillow body having an upper surface cloth and a lower surface cloth with an edge cloth as a boundary, a depression part including a bottom surface at a position depressed from the upper surface cloth to the lower surface cloth of the pillow body and a grooved part extending from the depression part to the edge cloth of the pillow body and being formed by joining the upper surface cloth to the lower surface cloth.Type: GrantFiled: February 22, 2007Date of Patent: September 20, 2011Inventor: Kenjiro Sato
-
Patent number: 7915267Abstract: The present invention provides a novel amide compound represented by the following formula, which has a matrix metalloproteinase inhibitory activity and is useful as a pharmaceutical agent. wherein each symbol is as defined in the specification.Type: GrantFiled: October 27, 2006Date of Patent: March 29, 2011Assignee: Takeda Pharmaceutical Company LimitedInventors: Hiroshi Nara, Akira Kaieda, Kenjiro Sato, Jun Terauchi
-
Publication number: 20100229307Abstract: Considering a case where a patient with whiplash syndrome can sleep safely, it is when the patient is sleeping at an appropriate orientation, whereby if a pillow enabling sleep while maintaining an appropriate orientation exists, a sick person can sleep peacefully, and furthermore, the pillow may be useful in treating the whiplash syndrome. A pillow enabling the patient with whiplash syndrome to sleep peacefully is thus developed. A pillow 1 of the present invention has a deformable pillow body 2 including an upper surface cloth 21 and a lower surface cloth 22 having an edge cloth 23 as a boundary, formed with a head depression part 4 including a bottom surface 41 at a position depressed from the upper surface cloth 21 to the lower surface cloth 22 of the pillow body 2, and a groove part 6 extending from the head depression part 4 to the edge cloth 23 of the pillow body 2 and being formed by joining the upper surface cloth 21 to the lower surface cloth 22.Type: ApplicationFiled: February 22, 2007Publication date: September 16, 2010Inventor: Kenjiro Sato
-
Patent number: 7722801Abstract: The vacuum carburizing apparatus introduces a carburizing gas into a carburizing chamber to subject the treatment material to vacuum carburizing. The vacuum carburizing apparatus comprises a carburizing chamber that houses a treatment material therein, a vacuum pump that exhausts gas from the carburizing chamber inside to obtain vacuum, a carburizing gas supply unit that supplies carburizing gas into the carburizing chamber in pulse mode, a reflux pipe which connects an intake side of the vacuum pump and an exhaust side of the vacuum pump, an opening and closing valve which is provided on the way of the reflux pipe, and a control unit which opens the opening and closing valve when a supply of the carburizing gas into the carburizing chamber is started, wherein the control unit closes the opening and closing valve when the supply ends.Type: GrantFiled: August 29, 2007Date of Patent: May 25, 2010Assignee: Daido Tokushuko Kabushiki KaishaInventor: Kenjiro Sato